Tagliabue E - Search Results

1

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.

Castagnoli L, Ghedini GC, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini PL, Nanni P, Chiodoni C, Tagliabue E, Pupa SM. Castagnoli L, et al. Among authors: tagliabue e. Oncogene. 2017 Mar 23;36(12):1721-1732. doi: 10.1038/onc.2016.338. Epub 2016 Sep 19. Oncogene. 2017. PMID: 27641338 Free PMC article.

2

Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.

Tagliabue E, Centis F, Campiglio M, Mastroianni A, Martignone S, Pellegrini R, Casalini P, Lanzi C, Ménard S, Colnaghi MI. Tagliabue E, et al. Int J Cancer. 1991 Apr 1;47(6):933-7. doi: 10.1002/ijc.2910470625. Int J Cancer. 1991. PMID: 1672668

3

Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.

Mezzanzanica D, Canevari S, Ménard S, Pupa SM, Tagliabue E, Lanzavecchia A, Colnaghi MI. Mezzanzanica D, et al. Among authors: tagliabue e. Int J Cancer. 1988 Apr 15;41(4):609-15. doi: 10.1002/ijc.2910410422. Int J Cancer. 1988. PMID: 3258590

4

Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.

Pellegrini R, Mariotti A, Tagliabue E, Bressan R, Bunone G, Coradini D, Della Valle G, Formelli F, Cleris L, Radice P, et al. Pellegrini R, et al. Among authors: tagliabue e. Cell Growth Differ. 1995 Jul;6(7):863-9. Cell Growth Differ. 1995. PMID: 7547508

5

Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.

Magnifico A, Tagliabue E, Ardini E, Casalini P, Colnaghi MI, Ménard S. Magnifico A, et al. Among authors: tagliabue e. FEBS Lett. 1998 Jan 30;422(2):129-31. doi: 10.1016/s0014-5793(97)01612-8. FEBS Lett. 1998. PMID: 9489990 Free article.

6

c-erbB-2 expression in primary breast cancer.

Tagliabue E, Ménard S, Robertson JF, Harris L. Tagliabue E, et al. Int J Biol Markers. 1999 Jan-Mar;14(1):16-26. doi: 10.1177/172460089901400104. Int J Biol Markers. 1999. PMID: 10367245 Free article. Review.

7

Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

Balsari A, Casalini P, Tagliabue E, Greco M, Pilotti S, Agresti R, Giovanazzi R, Alasio L, Rumio C, Cascinelli N, Colnaghi MI, Ménard S. Balsari A, et al. Among authors: tagliabue e. Am J Pathol. 1999 Nov;155(5):1543-7. doi: 10.1016/S0002-9440(10)65470-3. Am J Pathol. 1999. PMID: 10550311 Free PMC article.

8

Role of HER2 gene overexpression in breast carcinoma.

Ménard S, Tagliabue E, Campiglio M, Pupa SM. Ménard S, et al. Among authors: tagliabue e. J Cell Physiol. 2000 Feb;182(2):150-62. doi: 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E. J Cell Physiol. 2000. PMID: 10623878 Review.

9

Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.

Ménard S, Aiello P, Tagliabue E, Rumio C, Lollini PL, Colnaghi MI, Balsari A. Ménard S, et al. Among authors: tagliabue e. Cancer Res. 2000 Jan 15;60(2):273-5. Cancer Res. 2000. PMID: 10667575

10

Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells.

Tagliabue E, Castiglioni F, Ghirelli C, Modugno M, Asnaghi L, Somenzi G, Melani C, Ménard S. Tagliabue E, et al. J Biol Chem. 2000 Feb 25;275(8):5388-94. doi: 10.1074/jbc.275.8.5388. J Biol Chem. 2000. PMID: 10681513 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page